Drawing based on the label description. No photo yet.
“27 mg: gray, capsule shaped film coated tablets, imprinted with "A27" on one side and plain on the other side”
A27 pill
Pill with imprint A27 is gray, capsule, 13 mm and has been identified as Methylphenidate Hydrochloride 27 mg. It is used for depression, ADHD and narcolepsy. It is supplied by Lannett Company, Inc.
Controlled substance: Schedule II
Methylphenidate Hydrochloride 27 mg
- Imprint
- A27
- Strength
- 27 mg
- Used for
- Depression, ADHD and narcolepsy
- Color
- Gray
- Shape
- Capsule / oblong
- Size
- 13 mm
- Score
- No score line
- Form
- Tablet, extended release
- Manufacturer
- Lannett Company, Inc
- Drug class
- Stimulant (ADHD medicine)
- NDC
- 0527-3311, 0527-3311-37
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Methylphenidate used for?
Methylphenidate is used for depression, ADHD and narcolepsy.
- Medicine type
- Stimulant (ADHD medicine)
Official uses from the US prescribing label
Methylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
Limitations of Use
The use of methylphenidate hydrochloride extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.
From the FDA-approved label on DailyMed (published Sep 21, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows A27 and the other side is plain.
- It is gray, capsule, 13 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Methylphenidate Hydrochloride
Inactive: Hypromellose, Unspecified, Hypromellose 2910 (6 Mpa.s), Lactose Monohydrate, Microcrystalline Cellulose, Ethylcelluloses, Silicon Dioxide, Magnesium Stearate, Methacrylic Acid - Methyl Methacrylate Copolymer (1:1), Methacrylic Acid - Methyl Methacrylate Copolymer (1:2), Triethyl Citrate, Talc, Ferrosoferric Oxide, Titanium Dioxide, Ferric Oxide Yellow, Polyethylene Glycol 400, Shellac, Ammonia
Other pills with imprint A 27
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G 367
Topiramate 25 mg
Gray & pink, capsule, 14 mm
Used for bipolar disorder and focal seizures
-
AMNEAL 265
Oseltamivir 45 mg
Gray, capsule, 14 mm
Used for flu
-
RDY 597
Memantine 10 mg
Gray, capsule, 12 mm
Used for Alzheimer's disease
-
IP174
Memantine 10 mg
Gray, capsule, 12 mm
Used for Alzheimer's disease
-
150 G220
Lithium Carbonate 150 mg
Gray, capsule, 14 mm
Used for depression and PTSD
-
5241 0 5 mg
Anagrelide Hydrochloride 0.5 mg
Gray & white, capsule, 14 mm
Used for polycythemia vera and thrombocytosis
Other Methylphenidate pills
-
CP 401 10mg
Methylphenidate Hydrochloride 10 mg
Green & white, capsule, 14 mm
Used for depression and ADHD
Schedule II
-
10 M
Methylphenidate Hydrochloride 10 mg
White, round, 7 mm
Used for depression and ADHD
Schedule II
-
IRONSHORE 100mg
Methylphenidate Hydrochloride 100 mg
Blue & white, capsule, 23 mm
Used for depression and ADHD
Schedule II
-
212
Methylphenidate Hydrochloride 18 mg
Yellow, round, 12 mm
Used for depression and ADHD
Schedule II
-
Tow CHEW 2point5
Methylphenidate Hydrochloride 2.5 mg
White, round, 7 mm
Used for depression and ADHD
Schedule II
-
CP 402 20mg
Methylphenidate Hydrochloride 20 mg
Blue & white, capsule, 16 mm
Used for depression and ADHD
Schedule II
-
IRONSHORE 20mg
Methylphenidate Hydrochloride 20 mg
Green & yellow, capsule, 14 mm
Used for depression and ADHD
Schedule II
-
213
Methylphenidate Hydrochloride 27 mg
Pink, round, 12 mm
Used for depression and ADHD
Schedule II